Skip to content
Haemonetics LogoMedSurg
Back to Parent Page

Vascular Closure

Rapid hemostasis for arterial and venous access sites
Our portfolio of vascular closure products provides rapid hemostasis for interventional and electrophysiology procedures to help clinicians reduce the risk of complications, improve patient satisfaction, and enable same day discharge.

Request Information

Optimizing Vascular Access Management
• Enables same day discharge following AF ablation with VASCADE MVP® and VASCADE MVP® XL venous vascular closure systems (VVCS)
• Reduces the risk of access site complications with VASCADE® vascular closure system (VCS), as demonstrated in the RESPECT Clinical Trial1
• VASCADE family offers an outcomes-based risk-sharing VASCADE Performance Guarantee program – Sharing Risk by Sharing Costs™

Vascade

VASCADE®

The only closure device proven safer than manual compression in a randomized clinical trial with zero major complications.1,2

Learn More
Vascade MVP

VASCADE MVP®

Elegantly simple and easy to use, with 0% major complications in >1,000 patients in 5 EP clinical trials.3-7

Learn More
Vascade MVP XL

VASCADE MVP® XL

Now with an expanded indication for 10-14F inner diameter (17F max outer diameter) sheaths. Simply Bigger with 58% more collagen and a 9% larger disc compared to VASCADE MVP®.8 

 

Learn More

Fellows Development

An educational forum for Electrophysiology, Interventional Cardiology, Interventional Radiology, and Vascular Surgery fellows to increase their awareness and share best practices related to vascular closure. Our goal is to help fellows hone their vascular closure skills.

Learn More

Same Day Discharge

Electrophysiologists across the nation are achieving early ambulation and implementing same day discharge programs using the VASCADE MVP® and VASCADE MVP® XL systems. Read the latest clinical publications and hear from other EP physicians in our Same Day Discharge webinars and presentations.

Learn More
1. Hermiller JB, et.al. A Prospective, Randomized, Pivotal Trial of a Novel Extravascular Collagen-Based Closure Device Compared to Manual Compression in Diagnostic and Interventional Patients Journal of Invasive Cardiology 2015;27(3):129-136.

2. IFUs and / or SSEDs of commercially available leading brands (VASCADE®, AngioSeal®, Mynx®, Perclose™, Starclose™, Exoseal®). Major complications defined as major access site closure related complications per limb through follow-up period.

3. Natale A, et al. Venous vascular closure system versus manual compression following multiple access electrophysiology procedures: The AMBULATE Trial. JACC Clin Electrophysiol 2020; 6(1):111-124.

4. Al-Ahmad A, et al. Results from the prospective, multicenter AMBULATE-CAP trial: Reduced use of urinary catheters and protamine with hemostasis via the mid-bore venous vascular closure system. VASCADE MVP following multi-access cardiac ablation procedures. J Cardiovasc Electrophysiol 2021. 32(2): 191-99.

5. AMBULATE Same Day Discharge Registry Retrospective Study: NCT04538781.

6/7. Eldadah ZA, et al. Same-day discharge following catheter ablation and venous closure with VASCADE MVP: A post-market registry. J Cardiovasc Electrophysiol 2022. https://doi.org/10.1111/jce.15763 NCT04203329.

8. VASCADE MVP XL IFU 4911


 COL-COPY-002256-US(AD)

Connect with us

Haemonetics Vascular Closure LinkedIn Haemonetics Vascular Closure Twitter